PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 65 filers reported holding PTC THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $517,000 | -0.2% | 8,500 | -15.0% | 0.08% | 0.0% |
Q4 2014 | $518,000 | -90.6% | 10,000 | -92.0% | 0.08% | -92.9% |
Q3 2014 | $5,501,000 | +40.3% | 125,000 | -16.7% | 1.13% | +8.9% |
Q2 2014 | $3,921,000 | -72.7% | 150,000 | -72.7% | 1.04% | -68.6% |
Q1 2014 | $14,377,000 | +2840.1% | 550,000 | +1809.7% | 3.31% | +2228.2% |
Q4 2013 | $489,000 | – | 28,800 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |